Streetbeat News

Products Services

TSLA

Elon Musk, CEO of Tesla, has announced that the company will allow the transfer of Full Self-Driving (FSD) capabilities as part of a one-time amnesty in Q3. This move could potentially increase the value of used Tesla vehicles equipped with FSD.

Portfolio Pulse from Bill Haddad

July 19, 2023 | 9:54 pm

TSLA

Tesla Inc has reported an 80% increase in 4680 cell production in Texas for Q2 over Q1.

Portfolio Pulse from Bill Haddad

July 19, 2023 | 9:49 pm

TSLA

Tesla has announced plans to increase its spending on artificial intelligence. The move is expected to enhance the company's self-driving technology and other AI-based systems.

Portfolio Pulse from Bill Haddad

July 19, 2023 | 9:44 pm

TSLA

Elon Musk, CEO of Tesla, has announced that the company is open to licensing its Full Self Driving software and is in early discussions with a major Original Equipment Manufacturer (OEM).

Portfolio Pulse from Bill Haddad

July 19, 2023 | 9:41 pm

NVDA

TSLA

Elon Musk, CEO of Tesla, has stated that the company plans to use both Nvidia and Dojo for their operations.

Portfolio Pulse from Bill Haddad

July 19, 2023 | 9:41 pm

SPCE

Virgin Galactic Holdings, Inc. (NYSE:SPCE) shares traded higher on Wednesday, adding to the week's gains. The company announced details for its second commercial flight, 'Galactic 02', set to launch on August 10. The flight will carry three private passengers, including an Olympian and a mother-daughter duo who won their seats in a draw. Virgin Galactic is also set to report earnings on August 1, with an expected loss of 51 cents per share on revenue of $2.52 million.

Portfolio Pulse from Ryan Gustafson

July 19, 2023 | 9:34 pm

PFE

Pfizer has reported results from an ongoing Phase 2 study on its Group B Streptococcus (GBS) maternal vaccine candidate, GBS6. The study, published in the New England Journal of Medicine, showed that the vaccine was well-tolerated and generated robust maternal antibody responses that were efficiently transferred to infants. The safety profile was similar between the vaccine and placebo groups in both mothers and infants.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 9:25 pm

ALNY

Alnylam Pharmaceuticals has reported the publication of Phase 1 study results for Zilebesiran in the New England Journal of Medicine. The data showed that Zilebesiran was associated with dose-dependent reductions in serum AGT, achieving tonic blood pressure control with consistent and durable blood pressure reduction throughout a 24-hour period, sustained up to six months after single doses of ≥200 mg.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 9:01 pm

LTH

Life Time has announced that Australian activewear brand LSKD will be the exclusive apparel brand for its women's coaches, instructors, and trainers.

Portfolio Pulse from Bill Haddad

July 19, 2023 | 8:28 pm

META

WhatsApp, a service owned by Meta Platforms Inc., is reportedly experiencing issues, according to user reports on Downdetector.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 8:27 pm